Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of CarMax, Inc. (KMX) Shareholders GlobeNewswire December 04, 2025 NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in CarMax, Inc. (“CarMax, Inc.” or the “Company”) (NYSE: KMX) of a class action securities lawsuit. CLASS DEFINITION: The […]
Metallus (NYSE: MTUS), a leader in high-quality specialty metals, manufactured components, and supply chain solutions, and the United Steelworkers (USW) Local 1123 have reached a new tentative agreement for a four-year contract after the initial tentative agreement was not ratified by USW members on October 30, 2025. The date of the second vote will be
Vancouver, British Columbia–(Newsfile Corp. – December 4, 2025) – Cross River Ventures Corp. (CSE: CRVC.X) (the “Company” or “Cross River“) is pleased to announce the closing of its non-brokered private placement (the “Private Placement”). In connection with the closing of the Private Placement the Company issued 144,000,000 common shares at a price of $0.005 per common
(NASDAQ:JCAP), MINNEAPOLIS, Dec. 04, 2025 (GLOBE NEWSWIRE) — Jefferson Capital, Inc. (NASDAQ: JCAP) (“Jefferson Capital”), a leading analytically driven purchaser and manager of charged-off, insolvency and active consumer accounts, today completed the previously announced portfolio acquisition of credit card assets from affiliates of Bluestem Brands. The net purchase price for the portfolio was $196.7 million
(NASDAQ:PRAX), Successful interim analysis triggered early stop for efficacy Topline study results to be shared at the American Epilepsy Society Annual Meeting on December 6, 2025 Praxis confirms an upcoming meeting with the FDA to discuss the results and NDA path BOSTON, Dec. 04, 2025 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a
Jefferson Capital Completes Acquisition of Credit Card Portfolio GlobeNewswire December 04, 2025 MINNEAPOLIS, Dec. 04, 2025 (GLOBE NEWSWIRE) — Jefferson Capital, Inc. (NASDAQ: JCAP) (“Jefferson Capital”), a leading analytically driven purchaser and manager of charged-off, insolvency and active consumer accounts, today completed the previously announced portfolio acquisition of credit card assets from affiliates of Bluestem
Praxis Precision Medicines Announces Positive Results from EMBOLD Study for Relutrigine in SCN2A and SCN8A Developmental and Epileptic Encephalopathies GlobeNewswire December 04, 2025 Successful interim analysis triggered early stop for efficacy Topline study results to be shared at the American Epilepsy Society Annual Meeting on December 6, 2025 Praxis confirms an upcoming meeting with the
SmartMarket Solutions is proud to announce that the company has been awarded 1st Place for Business Opportunity of the Year at the 2025 Franchise Brokers Association (FBA) Award Ceremony. This recognition is especially significant as 2025 marks the company's inaugural year in the FBA inventory. https://mma.prnewswire.com/media/2839022/SmartMarket_Solutions.jpg Despite being a new addition, SmartMarket Solutions quickly emerged
A hearing has been scheduled before a hearing panel of the Canadian Investment Regulatory Organization (CIRO) pursuant to the Mutual Fund Dealer Rulesto consider a settlement agreement between CIRO Enforcement Staff andFranco Caligiuri. The settlement agreement addresses proposed allegations that Franco Caligiuri referred clients to an individual or company that offered for sale exempt securities,
(NASDAQ:SNCR), BALA CYNWYD, Pa., Dec. 04, 2025 (GLOBE NEWSWIRE) — Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Synchronoss Technologies (“Synchronoss” or the “Company”) (Nasdaq – SNCR) for possible breaches of fiduciary duty and other violations of federal and state law in connection with